🇮🇳 India
1h ago
Orbicular’s Ozempic generic gets U.S. FDA tentative nod
Source ↗
👁 0
💬 0
The product will be marketed and commercialised in the U.S. by Apotex, which is the ANDA applicant, complex peptide-based generics developer Orbicular said in a release.
Comments (0)